BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32448612)

  • 1. Advanced multimodal imaging in differentiating glioma recurrence from post-radiotherapy changes.
    Li C; Gan Y; Chen H; Chen Y; Deng Y; Zhan W; Tan Q; Xie C; Sharma HS; Zhang Z
    Int Rev Neurobiol; 2020; 151():281-297. PubMed ID: 32448612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential for differentiation of glioma recurrence from radionecrosis using integrated
    Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
    Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
    Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
    J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous
    Jena A; Taneja S; Jha A; Damesha NK; Negi P; Jadhav GK; Verma SM; Sogani SK
    AJNR Am J Neuroradiol; 2017 May; 38(5):899-907. PubMed ID: 28341716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
    Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
    Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
    Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
    Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of Recurrence from Radiation Necrosis in Gliomas Based on the Radiomics of Combinational Features and Multimodality MRI Images.
    Zhang Q; Cao J; Zhang J; Bu J; Yu Y; Tan Y; Feng Q; Huang M
    Comput Math Methods Med; 2019; 2019():2893043. PubMed ID: 31871484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI.
    Jena A; Taneja S; Gambhir A; Mishra AK; Dʼsouza MM; Verma SM; Hazari PP; Negi P; Jhadav GK; Sogani SK
    Clin Nucl Med; 2016 May; 41(5):e228-36. PubMed ID: 26859208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities.
    Alexiou GA; Tsiouris S; Kyritsis AP; Voulgaris S; Argyropoulou MI; Fotopoulos AD
    J Neurooncol; 2009 Oct; 95(1):1-11. PubMed ID: 19381441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the utility of
    Crain ID; Elias PS; Chapple K; Scheck AC; Karis JP; Preul MC
    J Neurooncol; 2017 May; 133(1):97-105. PubMed ID: 28555423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
    Hojjati M; Badve C; Garg V; Tatsuoka C; Rogers L; Sloan A; Faulhaber P; Ros PR; Wolansky LJ
    J Neuroimaging; 2018 Jan; 28(1):118-125. PubMed ID: 28718993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between glioma recurrence and radiation-induced necrosis: in regards to Qing-Shi et al. (Int J Radiat Oncol Biol Phys 2007;68:151-158).
    Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1585-6; author reply 1586. PubMed ID: 17674998
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.
    Sonoda Y; Kumabe T; Takahashi T; Shirane R; Yoshimoto T
    Neurol Med Chir (Tokyo); 1998 Jun; 38(6):342-7; discussion 347-8. PubMed ID: 9689817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Performance of PET and Perfusion-Weighted Imaging in Differentiating Tumor Recurrence or Progression from Radiation Necrosis in Posttreatment Gliomas: A Review of Literature.
    Soni N; Ora M; Mohindra N; Menda Y; Bathla G
    AJNR Am J Neuroradiol; 2020 Sep; 41(9):1550-1557. PubMed ID: 32855194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Dynamic Susceptibility Contrast Perfusion-Weighted MR Imaging and
    Qiao Z; Zhao X; Wang K; Zhang Y; Fan D; Yu T; Shen H; Chen Q; Ai L
    AJNR Am J Neuroradiol; 2019 Feb; 40(2):253-259. PubMed ID: 30655259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of MRI, F-18 FDG, and 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy.
    Tan H; Chen L; Guan Y; Lin X
    Clin Nucl Med; 2011 Nov; 36(11):978-81. PubMed ID: 21975383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
    Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH
    Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.
    D'Souza MM; Sharma R; Jaimini A; Panwar P; Saw S; Kaur P; Mondal A; Mishra A; Tripathi RP
    Clin Nucl Med; 2014 Sep; 39(9):791-8. PubMed ID: 25036022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of residual/recurrent gliomas from postradiation necrosis with arterial spin labeling and diffusion tensor magnetic resonance imaging-derived metrics.
    Razek AAKA; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
    Neuroradiology; 2018 Feb; 60(2):169-177. PubMed ID: 29218370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.